Therapeutic drug monitoring
Extracorporeal Membrane Oxygenation Can Affect Posaconazole Exposure in Critically Ill Patients.
Ming G Chai, Rekha P Mangalore, Joshua F Ihle, Miranda A Paraskeva, Steven A McGloughlin, Bradley J Gardiner
Published: 202610.1097/FTD.0000000000001437
Abstract
BACKGROUND: Posaconazole is an antifungal agent used to prevent or treat invasive fungal infections (IFIs) in critically ill patients, including those receiving extracorporeal membrane oxygenation (ECMO). However, in vitro data suggest that posaconaz…
Preview only. Read the full abstract at the source